Cervical cancer prevention: immunization and screening 2015.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25841595.
- Also identified by DOI 10.1016/j.mcna.2015.01.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Both primary and secondary prevention of cervical cancer are now available. Immunizations against human papillomavirus (HPV) types 16 and 18 have the potential to prevent 70% of cancers of the cervix plus a large percentage of other lower anogenital tract cancers. Screening guidelines were recently changed to recommend cotesting with cytology plus an HPV test. The addition of HPV testing increases the sensitivity and negative predictive value of screening over the Papanicolaou (Pap) test alone.
Medical subject headings
- Mass Screening
- Uterine Cervical Neoplasms